← Back to headlines
Novo Nordisk Lowers Prices for Ozempic and Wegovy in Spain
Novo Nordisk has announced price reductions of up to 17.6% for its diabetes and obesity drugs, Ozempic and Wegovy, in Spain, with Wegovy's highest dose dropping to 223.64 euros.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Philippine Justice Questions Identity of 'SBR' in Flood Control Project
just now
Philippine Government Addresses Supply Chain Concerns
just now
ESRI Study Predicts AI Adoption Will Lead to Job Losses in Irish Firms
12m ago
McKinsey Report Highlights AI as Driver of Global Trade Growth Amid Geopolitical Shifts
13m ago